The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693 · cited 2×
“cells, RPA binds single-stranded DNA and interacts with ATR interacting protein (ATRIP), thus recruiting ATR (Zou and Elledge, 2003).”
BackgroundThe RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 2×
“Deregulation of the Rb tumour suppressor pathway, for example, will lead to aberrant activation of E2F, resulting in increased levels of ARF (Sherr and McCormick, 2002).”
BackgroundHistone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress
Ward, I. M., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100569200 · Cited by 1,150
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819 · cited 1×
“Furthermore, in model systems, tumours that retain wild-type p53 will often lose ARF expression (Eischen et al, 1999). p53- and Hdm2-independent effects of ARF have also been reported, such as inhibition of ribosomal RNA processing and association with nucleophosmin/B23 (Sugimoto et al, 2003;…”
BackgroundATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 731 · cited 1×
“These could include Hdm2, a known ATR/ATM substrate (Khosravi et al, 1999; de Toledo et al, 2000; Maya et al, 2001; Shinozaki et al, 2003), and other transcription factors or proteins with proliferative or antiapoptotic functions.”
BackgroundTumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · cited 8×
“ARF is therefore a critical link in the chain from oncogene activation to p53 induction, and this is reflected by the fact that it is often inactivated by mutation or gene methylation in tumour cells (Sherr, 2001; Esteller, 2002; Lowe and Sherr, 2003).”
BackgroundInfluentialTranscriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598 · cited 1×
“These include descriptions of RelA being required for induction of p53 (Ryan et al, 2000; Fujioka et al, 2004), as well as inhibiting its activity (Webster and Perkins, 1999; Tergaonkar et al, 2002).”
BackgroundSelf-citationFunctional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512
Furuta, T., Takemura, H., Liao, Z.-Y., Aune, G. J., Redon, C., Sedelnikova, O. A., Pilch, D. R., Rogakou, E. P., Celeste, A., Chen, H. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300198200 · Cited by 449
Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53
Zhai, W., & Comai, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5930-5938.2000 · Cited by 289 · cited 1×
“A nucleolar function for p53 is possible since a role inhibiting pol I-dependent gene expression has been previously described (Budde and Grummt, 1999; Zhai and Comai, 2000).”
BackgroundStojic, L., Mojas, N., Cejka, P., di Pietro, M., Ferrari, S., Marra, G., & Jiricny, J. (2004) · Genes & Development · doi:10.1101/gad.294404 · Cited by 246 · cited 1×
“A previous study had found that this phospho-SQ/TQ antibody recognised specific nuclear complexes (Stojic et al, 2004).”
BackgroundINK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence
Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf289 · Cited by 220
p53 represses ribosomal gene transcription
Budde, A., & Grummt, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202402 · Cited by 157
Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export
Shinozaki, T., Nota, A., Taya, Y., & Okamoto, K. (2003) · Oncogene · doi:10.1038/sj.onc.1207176 · Cited by 93 · cited 1×
“These could include Hdm2, a known ATR/ATM substrate (Khosravi et al, 1999; de Toledo et al, 2000; Maya et al, 2001; Shinozaki et al, 2003), and other transcription factors or proteins with proliferative or antiapoptotic functions.”
Background
Research works printed but not linked: 36
- Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15: 2177–2196 · DOI · Paper page
- Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421–429 · DOI · Paper page
- Bertwistle D, Sugimoto M, Sherr CJ (2004) Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 24: 985–996 · DOI · Paper page
- Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by ReIA(p65) NF‐κB. Mol Cell 13: 853–865 · DOI · Paper page
- de Toledo SM, Azzam EI, Dahlberg WK, Gooding TB, Little JB (2000) ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53‐independent manner in normal and tumor human cells exposed to ionizing radiation. Oncogene 19: 6185–6193 · DOI
- Dumaz N, Meek DW (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18: 7002–7010 · DOI · Paper page
- Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427–5440 · DOI · Paper page
- Eymin B, Karayan L, Seite P, Brambilla C, Brambilla E, Larsen CJ, Gazzeri S (2001) Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 20: 1033–1041 · DOI · Paper page
- Fatyol K, Szalay AA (2001) The p14(ARF) tumor suppressor protein facilitates nucleolar sequestration of hypoxia‐inducible factor‐1 α (HIF‐1 α) and inhibits HIF‐1‐mediated transcription. J Biol Chem 276: 28421–28429 · DOI
- Foray N, Marot D, Gabriel A, Randrianarison V, Carr AM, Perricaudet M, Ashworth A, Jeggo P (2003) A subset of ATM‐ and ATR‐dependent phosphorylation events requires the BRCA1 protein. EMBO J 22: 2860–2871 · DOI · Paper page
- Fujioka S, Schmidt C, Sclabas GM, Li ZK, Pelicano H, Peng B, Yao A, Niu JG, Zhang W, Evans DB, Abbruzzese JL, Huang P, Chiao PJ (2004) Stabilization of p53 is a novel mechanism for proapoptotic function of NF‐κB. J Biol Chem 279: 27549–27559 · DOI
- Hammond EM, Dorie MJ, Giaccia AJ (2003) ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 278: 12207–12213 · DOI · Paper page
- Hutchins JRA, Hughes M, Clarke PR (2000) Substrate specificity determinants of the checkpoint protein kinase Chk1. FEBS Lett 466: 91–95 · DOI
- Ishimi Y, Komamura‐Kohno Y, Kwon HJ, Yamada K, Nakanishi M (2003) Identification of MCM4 as a target of the DNA replication block checkpoint system. J Biol Chem 278: 24644–24650 · DOI
- Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D (1999) Rapid ATM‐dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 96: 14973–14977 · DOI · Paper page
- Kohn EA, Yoo CJ, Eastman A (2003) The protein kinase c inhibitor Go6976 is a potent inhibitor of DNA damage‐induced S and G(2) cell cycle checkpoints. Cancer Res 63: 31–35
- Kuo M, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ, Roussel MF (2003) Arf induces p53‐dependent and ‐independent antiproliferative genes. Cancer Res 63: 1046–1053
- Lai JS, Herr W (1992) Ethidium‐bromide provides a simple tool for identifying genuine DNA‐independent protein associations. Proc Natl Acad Sci USA 89: 6958–6962 · DOI · Paper page
- Li Y, Wu D, Chen B, Ingram A, He L, Liu L, Zhu D, Kapoor A, Tang D (2004) ATM activity contributes to the tumor‐suppressing functions of p14(ARF). Oncogene 23: 7355–7365 · DOI
- Lindstrom MS, Wiman KG (2003) Myc and E2F1 induce p53 through p14ARF‐independent mechanisms in human fibroblasts. Oncogene 22: 4993–5005 · DOI
- Llanos S, Clark PA, Rowe J, Peters G (2001) Stabilization of p53 by p14(ARF) without relocation of MDM2 to the nucleolus. Nat Cell Biol 3: 445–452 · DOI · Paper page
- Mason SL, Loughran O, La Thangue NB (2002) p14(ARF) regulates E2F activity. Oncogene 21: 4220–4230 · DOI
- Michael D, Oren M (2002) The p53 and Mdm2 families in cancer. Curr Opin Genet Dev 12: 53–59 · DOI · Paper page
- Perkins ND (2004) NF‐κB: tumor promoter or suppressor? Trends Cell Biol 14: 64–69 · DOI · Paper page
- Rocha S, Campbell KJ, Perkins ND (2003) p53‐ and Mdm2‐independent repression of NF‐κB transactivation by the ARF tumor suppressor. Mol Cell 12: 15–25 · DOI · Paper page
- Roche KC, Wiechens N, Hughes TO, Perkins ND (2004) The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression. Oncogene 23: 8185–8195 · DOI
- Rodway H, Llanos S, Rowe J, Peters G (2004) Stability of nucleolar vs non‐nucleolar forms of human p14(ARF). Oncogene 23: 6186–6192 · DOI
- Ryan KM, Ernst MK, Rice NR, Vousden KH (2000) Role of NF‐κB in p53‐mediated programmed cell death. Nature 404: 892–897 · DOI · Paper page
- Sherr CJ (2001) The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2: 731–737 · DOI · Paper page
- Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, El‐Deiry WS (1999) BRCA1 signals ARF‐dependent stabilization and coactivation of p53. Oncogene 18: 6605–6614 · DOI
- Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G (1998) The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17: 5001–5014 · DOI · Paper page
- Sugimoto M, Kou M, Roussel MF, Sherr CJ (2003) Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 11: 415–424 · DOI · Paper page
- Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I (2002) p53 stabilization is decreased upon NFκB activation: a role for NFκB in acquisition of resistance to chemotherapy. Cancer Cell 1: 493–503 · DOI · Paper page
- Vousden KH (2002) Activation of the p53 tumor suppressor protein. BBBA Rev Cancer 1602: 47–59
- Ward IM, Minn K, Chen JJ (2004) UV‐induced ataxia‐telangiectasia‐mutated and Rad3‐related (ATR) activation requires replication stress. J Biol Chem 279: 9677–9680 · DOI · Paper page
- Yarden RI, Pardo‐Reoyo S, Sgagias M, Cowan KH, Brody LC (2002) BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30: 285–289 · DOI · Paper page
Cited by
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Self-citationCrosstalk in NF-κB Signaling Pathways
Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011) · Nature Immunology · doi:10.1038/ni.2065 · Cited by 1,942
The target landscape of clinical kinase drugs
Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P.-A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., et al. (2017) · Science · doi:10.1126/science.aan4368 · Cited by 854
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
Self-citation
Metadata
- Authors
- Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D.
- Venue
- The EMBO Journal
- Published
- 2005-03-10
- Volume
- 24
- Issue
- 6
- Pages
- 1157-1169
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2126415922
- Cited by
- 162
- References
- 14
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.